34 related articles for article (PubMed ID: 6992234)
1. Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A.
Malty RH; Hudmon A; Fehrenbacher JC; Vasko MR
J Neuroinflammation; 2016 Jul; 13(1):181. PubMed ID: 27400965
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of fat storage by prostacyclin and selective agonists of prostanoid IP receptor during the maturation phase of cultured adipocytes.
Khan F; Syeda PK; Nartey MN; Rahman MS; Islam MS; Nishimura K; Jisaka M; Shono F; Yokota K
Cytotechnology; 2016 Dec; 68(6):2417-2429. PubMed ID: 26946143
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for iloprost as a dual peroxisome proliferator-activated receptor alpha/delta agonist.
Jin L; Lin S; Rong H; Zheng S; Jin S; Wang R; Li Y
J Biol Chem; 2011 Sep; 286(36):31473-9. PubMed ID: 21775429
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouse.
Armstrong PC; Kirkby NS; Zain ZN; Emerson M; Mitchell JA; Warner TD
PLoS One; 2011; 6(5):e20062. PubMed ID: 21629780
[TBL] [Abstract][Full Text] [Related]
5. Mechano- and chemosensitivity of rat nodose neurones--selective excitatory effects of prostacyclin.
Snitsarev V; Whiteis CA; Chapleau MW; Abboud FM
J Physiol; 2007 Jul; 582(Pt 1):177-94. PubMed ID: 17478531
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway.
Kamio K; Liu X; Sugiura H; Togo S; Kobayashi T; Kawasaki S; Wang X; Mao L; Ahn Y; Hogaboam C; Toews ML; Rennard SI
Am J Respir Cell Mol Biol; 2007 Jul; 37(1):113-20. PubMed ID: 17363776
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.
Trifan OC; Hla T
J Cell Mol Med; 2003; 7(3):207-22. PubMed ID: 14594546
[TBL] [Abstract][Full Text] [Related]
8. cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases.
Tertyshnikova S; Yan X; Fein A
J Physiol; 1998 Oct; 512 ( Pt 1)(Pt 1):89-96. PubMed ID: 9729619
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inositol 1,4,5-trisphosphate-induced Ca2+ release by cAMP-dependent protein kinase in a living cell.
Tertyshnikova S; Fein A
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1613-7. PubMed ID: 9465064
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.
de Brum-Fernandes AJ; Morisset S; Bkaily G; Patry C
Br J Pharmacol; 1996 Aug; 118(7):1597-604. PubMed ID: 8842420
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of prostacyclin receptors in a neuronal hybrid cell line.
Blair IA; Leigh PJ; MacDermot J
Br J Pharmacol; 1982 Sep; 77(1):121-7. PubMed ID: 6289953
[TBL] [Abstract][Full Text] [Related]
12. The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.
Schrör K; Darius H; Matzky R; Ohlendorf R
Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):252-5. PubMed ID: 6166877
[No Abstract] [Full Text] [Related]
13. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
[TBL] [Abstract][Full Text] [Related]
14. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
[TBL] [Abstract][Full Text] [Related]
15. Current issues in thrombosis prevention with antiplatelet drugs.
de Gaetano G; Cerletti C; Dejana E; Vermylen J
Drugs; 1986 Jun; 31(6):517-49. PubMed ID: 3525085
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic mechanisms, independent of platelet aggregation, arrest gastric mucosal bleeding.
Whittle BJ; Kauffman GL; Moncada S
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5683-7. PubMed ID: 3461455
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator actions of TRK-100, a new prostaglandin I2 analogue.
Akiba T; Miyazaki M; Toda N
Br J Pharmacol; 1986 Dec; 89(4):703-11. PubMed ID: 3101928
[TBL] [Abstract][Full Text] [Related]
18. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
Hamid S; Whittle BJ
Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
[TBL] [Abstract][Full Text] [Related]
19. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
Whittle BJ; Moncada S; Whiting F; Vane JR
Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
